mountsinaihospital.com
This role involves conducting research on myeloid malignancies using human pluripotent stem cells, including experiments with cell culture, differentiation, and genetic modification. The position also includes participating in studies to develop new models of COVID-19 by reprogramming patient cells to understand genetic predispositions to severe disease. Responsibilities encompass data analysis and presenting findings at lab meetings and seminars.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for mountsinaihospital.com.
mountsinaihospital.com didn’t post a salary, so this is our estimate from similar listings.
39% below the average for this role